Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates

Company Performance - Beyond Air, Inc. reported a quarterly loss of $1.53 per share, slightly worse than the Zacks Consensus Estimate of a loss of $1.50, but an improvement from a loss of $5.40 per share a year ago, indicating a significant year-over-year recovery [1] - The company posted revenues of $1.76 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.68%, but showing growth from $0.68 million in the same quarter last year [2] - Over the last four quarters, Beyond Air has surpassed consensus EPS estimates three times, but has only topped consensus revenue estimates once [2] Stock Performance - Beyond Air shares have declined approximately 55.9% since the beginning of the year, contrasting with the S&P 500's gain of 8.4% [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$1.30 on revenues of $2.46 million, and for the current fiscal year, it is -$5.00 on revenues of $13.1 million [7] - The estimate revisions trend for Beyond Air was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, suggesting it is expected to outperform the market in the near future [6] Industry Context - Beyond Air operates within the Medical - Biomedical and Genetics industry, which is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Beyond Air's stock may be influenced by the overall outlook for the industry, as research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]